J. Phillips

发表

Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (CGP 69846A) after intravenous and subcutaneous administration.

P. Nicklin, R. Geary, D. Bayley, 1997, Biochemical pharmacology.

Second Generation of Antisense Oligonucleotides: From Nuclease Resistance to Biological Efficacy in Animals

S. Freier, D. Fabbro, F. Natt, 1996, CHIMIA.

Distribution of a 20-Mer Phosphorothioate Oligonucleotide, CGP69846A (ISIS 5132), into Airway Leukocytes and Epithelial Cells Following Intratracheal Delivery to Brown-Norway Rats

J. Giddings, H. Danahay, H. Moser, 1999, Pharmaceutical Research.

Antisense Research and Application

G. Schultz, P. Nielsen, R. Zhang, 1998, Handbook of Experimental Pharmacology.

Pharmacokinetic Properties of Phosphorothioates in Animals — Absorption, Distribution, Metabolism and Elimination

P. Nicklin, J. Phillips, S. J. Craig, 1998 .

Pulmonary Bioavailability of a Phosphorothioate Oligonucleotide (CGP 64128A): Comparison with Other Delivery Routes

J. Giddings, P. Nicklin, J. Hastewell, 1998, Pharmaceutical Research.

Peptide drug delivery: Colonic and rectal absorption

J. Hastewell, M. Mackay, J. Phillips, 1997 .

Inhibition antisens du stat 6 humain

P. Nicklin, J. Phillips, S. Hill, 1998 .

Secretory effects of kinins on colonic epithelium in relation to prostaglandins released from cells of the lamina propria

J. Hoult, J. Phillips, J. Phillips, 1988, British journal of pharmacology.

Kinin‐induced prostaglandin release in rat colon does not display serosal/mucosal ‘sidedness' after epithelial removal

J. Hoult, J. Phillips, 1986, British journal of pharmacology.